Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Bioregenx (BRGX) Shares Issued (2023)

Bioregenx (BRGX) has 1 years of Shares Issued data on record, last reported at $527088.0 in Q4 2023.

  • For Q4 2023, Shares Issued changed N/A year-over-year to $527088.0; the TTM value through Sep 2024 reached $527088.0, changed N/A, while the annual FY2023 figure was $1.3 million, N/A changed from the prior year.
  • Shares Issued reached $527088.0 in Q4 2023 per BRGX's latest filing, up from $63209.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $527088.0 in Q4 2023 and bottomed at $63209.0 in Q3 2023.